These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Mechanisms of the suppression of proliferation and invasion ability mediated by microRNA-147b in esophageal squamous cell carcinoma].
    Author: Tang Y, Li Z, Shi ZX.
    Journal: Zhonghua Yi Xue Za Zhi; 2018 Jul 10; 98(26):2092-2098. PubMed ID: 30032507.
    Abstract:
    Objective: To explore the expression of microRNA(miR)-147b in esophageal squamous cell carcinoma (ESCC) and its regulatory roles in cell proliferation, cell cycle and invasion as well as its molecular mechanisms. Methods: Real-time quantitative PCR (qPCR) was used to investigate the expression of miR-147b in ESCC tissues and cells. Negative control (NC) and miR-147b inhibitor were transfected into ESCC EC1 and EC9706 cells, which were divided into two groups: NC group and miR-147b inhibitor group, and qPCR was employed to detect the miR-147 level and CCK-8. Flow cytometry and Transwell chamber were utilized to investigate the effects of miR-147b downregulation on cell proliferation, cell cycle and invasion in ESCC cells. Besides, target genes of miR-147b was confirmed by double luciferase reporter assay. Subsequently, qPCR and Western blot were used to examine the effects of miR-147b downregulation on NDUFA4 expression, and NDUFA4 expression and its correlation with miR-147b were investigated in ESCC tissues. Results: Relative level of miR-147b in ESCC tissues (3.03±0.27) and cells were markedly higher than that in para-carcinoma tissues (1.00±0.01) and normal esophageal epithelial cell, and the differences had statistical significance (P<0.01), and its high expression was closely associated with clinical staging, invasion depth, histological grading and lymph node metastasis(P<0.05). Importantly, clinical staging, lymph node metastasis and miR-147b may be an independent prognostic factor in ESCC. Moreover, miR-147b downregulation dramatically suppressed cell proliferation, arrested cell cycle in G0/G1 phase and reduced invasion ability in ESCC cells. Most importantly, NDUFA4 was a direct target gene of miR-147b, and miR-147b inhibitor evidently upregulated the expression of NDUFA4. Furthermore, NDUFA4 displayed low expression in ESCC tissues and its expression exhibited negative correlation with miR-147b expression. Conclusions: The downregulation of miR-147b expression significantly suppresses the proliferation and invasion abilities as well as alters cell cycle distribution in ESCC. 目的: 探讨微RNA(microRNA,miR)-147b在食管鳞状细胞癌(以下简称"鳞癌")中的表达及其在细胞增殖、细胞周期和侵袭中的分子机制。 方法: 采用实时荧光定量PCR(qPCR)检测食管鳞癌组织和细胞中miR-147b的表达。将阴性对照(NC)和miR-147b抑制剂转染食管鳞癌EC1和EC9706细胞。试验分为两组:NC组和miR-147b抑制剂组,采用qPCR检测上述细胞中miR-147b的表达,采用CCK-8、流式细胞术和Transwell小室检测分别检测miR-147b表达下调对食管鳞癌细胞增殖、细胞周期和侵袭的影响。利用双荧光素酶报告载体分析其直接作用的靶基因。采用qPCR和Western印迹检测miR-147b表达下调对靶基因NDUFA4表达的影响,进一步利用qPCR检测NDUFA4在食管鳞癌组织中的表达,并分析其表达与miR-147b表达的相关性。 结果: 食管鳞癌组织(3.03±0.27)和细胞中miR-147b的相对表达水平均显著高于癌旁组织(1.00±0.01)和正常食管上皮细胞,差异均有统计学意义(均P<0.01),并且miR-147b高表达与食管鳞癌患者的临床分期、浸润深度、组织学分级及淋巴结转移均密切相关(均P<0.05),临床分期、淋巴结转移和miR-147b是食管鳞癌患者的独立预后因素。miR-147b表达下调能显著抑制食管鳞癌细胞的增殖、静止细胞周期在G0/G1期和降低其侵袭能力。NDUFA4是miR-147b直接作用的靶基因,miR-147b抑制剂显著增加食管鳞癌EC1和EC9706细胞中NDUFA4的表达。NDUFA4在食管鳞癌组织中表达显著下调,其与miR-147b的表达负相关(r=-0.765,P<0.001)。 结论: miR-147b表达的下调显著抑制食管鳞癌的增殖和侵袭能力,且可以改变其细胞周期分布。.
    [Abstract] [Full Text] [Related] [New Search]